Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic's Deal with Affymetrix Aims to Add Value to Expression Data

Premium

GAITHERSBURG, Md.--With access to Gene Logic's database of 50,000 proprietary gene sequences, Affymetrix will design and manufacture a series of custom microarrays. The companies said the custom arrays will complement Affymetrix's current 60,000 human gene set and will accelerate the pace at which Gene Logic achieves full genome coverage for the samples used in the GeneExpress database.

Meanwhile, Gene Logic released the next generation of its GeneExpress database. GeneExpress 2000 is a reference set of gene expression information across a range of normal and diseased human tissues, experimental animals, and disease models and cell lines. The new version replaces the first generation of software that was released to support the database in November 1999, and will be deployed to all current commercial users of the database.

Filed under

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.